Literature DB >> 15201466

Oxidative damage in Huntington's disease.

José Segovia1, Francisca Pérez-Severiano.   

Abstract

Huntington's disease is a hereditary neurodegenerative disorder, characterized by motor, psychiatric, and cognitive symptoms. The genetic defect responsible for the onset of the disease, expansion of CAG repeats in exon 1 of the gene that codes for huntingtin, has been unambiguously identified. On the other hand, the mechanisms by which the mutation causes the disease are not completely understood yet. However, defects in the energy metabolism of affected cells may cause oxidative damage, which has been proposed as one of the underlying molecular mechanism that participates in the etiology of the disease. This chapter describes methods to genotype mice transgenic for the disease, characterizing their progressive neurological phenotype, and biochemical methods that allow determining striatal oxidative damage, and establishing the status of both protective cellular systems, and biochemical pathways that induce the generation of free radicals. The methods described in this chapter permit one to relate the neurological phenotype of the mice with the degree of oxidative damage sustained by the brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15201466     DOI: 10.1385/1-59259-804-8:321

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway.

Authors:  Kuo-Feng Hua; A-Ching Chao; Ting-Yu Lin; Wan-Tze Chen; Yu-Chieh Lee; Wan-Han Hsu; Sheau-Long Lee; Hsin-Min Wang; Ding-I Yang; Tz-Chuen Ju
Journal:  J Ginseng Res       Date:  2021-11-11       Impact factor: 5.735

Review 2.  Targeting glial cells to elucidate the pathogenesis of Huntington's disease.

Authors:  Han-Yun Hsiao; Yijuang Chern
Journal:  Mol Neurobiol       Date:  2010-01-28       Impact factor: 5.590

3.  Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity.

Authors:  Sara T Al-Rashood; Ahmed R Hamed; Ghada S Hassan; Hamad M Alkahtani; Abdulrahman A Almehizia; Amal Alharbi; Mohammad M Al-Sanea; Wagdy M Eldehna
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.